Exploring the pharmacological mechanisms of Biyan Qingdu Granula in the treatment after nasopharyngeal carcinoma radiotherapy based on UPLC/Q-TOF MS, network pharmacology and molecular docking.

导出 LinkOut

翻译打印收藏纠错

作者： Bojiao,Yi ^[1] ; Fengyi,Lv ^[2] ; Na,Zhang ^[1] ; Juan,Lin ^[3] ; Keyi,Xu ^[3] ; Chuyuan,Li ^[3] ; Peng,Li ^[4] ; Min,Zhao ^[5]

作者单位： School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China; Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China. ^[1] Zhong Yuan Academy of Biological Medicine, Liaocheng People's Hospital, Liaocheng 252000, Shandong, China. ^[2] Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co., Ltd., Guangzhou 510515, China. ^[3] Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co., Ltd., Guangzhou 510515, China. Electronic address: 1554148518@qq.com. ^[4] School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China. Electronic address: zm19871224@sina.com. ^[5]

关键词 Biyan Qingdu Granula Molecular docking Nasopharyngeal carcinoma Network pharmacology UPLC/Q-TOF MS

主题词人类(Humans);色谱法, 高压液相(Chromatography, High Pressure Liquid);磷酸肌醇3-激酶类(Phosphatidylinositol 3-Kinases);鼻咽肿瘤(Nasopharyngeal Neoplasms);中草药(Drugs, Chinese Herbal)

DOI 10.1016/j.jpba.2023.115830

PMID 38096633

发布时间 2024-01-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交